Valspodar Completed Phase 3 Trials for Myelodysplastic Syndromes / Myelodysplastic/Myeloproliferative Neoplasms / Leukemias Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT00005823Intensive Compared With Nonintensive Chemotherapy in Treating Older Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome